Prostate Cancer in advanced stage. James L. Gulley, M.D., Ph.D., F.A.C.P. is Director, Clinical Trials Group and Deputy Chief, Laboratory of Tumor Immunology and Biology as well as the Senior Investigator iin the Medical Oncology Branch of the Center for Cancer Research, National Cancer Institute National Institutes of Health.
Joel Nowak, MSW, Director of Malecare Advanced Disease and Advocacy. This teleconference presents an overview of the new treatments now available for men with castrate resistant advanced prostate cancer including a discussion of the sequencing and combining of these treatments. They also talk about immunotherapies and their role in current treatment.
For more information about prostate cancer, visit http://malecare.org and http://advancedprostatecancer.net